NCT02509598 2024-06-28
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Cardinal Health 414, LLC
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Rhabdomyosarcoma × technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran × Clear all